COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2688: Articles 26871-26880  | Next

A pandemic at the Tunisian scale. Mathematical modelling of reported and unreported COVID-19 infected cases
Abdeljaoued-Tej, I.
10.1101/2020.05.21.20108621 — Posted: 2020-05-23
The Challenge of Using Epidemiological Case Count Data: The Example of Confirmed COVID-19 Cases and the Weather
Cohen, F., Schwarz, M., Li, S., Lu, Y., Jani, A.
10.1101/2020.05.21.20108803 — Posted: 2020-05-23
Forecasting trajectories of an emerging epidemic with mathematical modeling in an online dashboard: The case of COVID-19
Młocek, W., Lew, R.
10.1101/2020.05.21.20108753 — Posted: 2020-05-23
Improved measurement of racial/ethnic disparities in COVID-19 mortality in the United States
Goldstein, J. R., Atherwood, S.
10.1101/2020.05.21.20109116 — Posted: 2020-05-23
A score-based risk model for predicting severe COVID-19 infection as a key component of lockdown exit strategy
Dagan, N., Barda, N., Riesel, D., Grotto, I., Sadetzki, S., Balicer, R.
10.1101/2020.05.20.20108571 — Posted: 2020-05-23
Pathways of the COVID-19 Pandemic with Human Mobility across Countries
Zhang, C., Qian, L.-X., Hu, J.-Q.
10.1101/2020.05.21.20108589 — Posted: 2020-05-23
Estimating the size of the COVID-19 outbreak in Italy: Application of an exponential decay model to the weighted and cumulative average daily growth rate
Bartolomeo, N., Trerotoli, P., Serio, G.
10.1101/2020.05.20.20108241 — Posted: 2020-05-23
Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19
Rhee, S. Y., Lee, J., Nam, H., Kyoung, D.-S., Kim, D. J.
10.1101/2020.05.20.20108555 — Posted: 2020-05-23
Congregate Shelter Characteristics and Prevalence of Asymptomatic SARS-CoV-2
Samuels, E. A., Karb, R., Vanjani, R., Trimbur, M. C., Napoli, A.
10.1101/2020.05.21.20108985 — Posted: 2020-05-23
Validation of the Kuwait Progression Indicator Score for predicting progression of severity in COVID19
Al Youha, S., Doi, S. A., Jamal, M. H., Almazeedi, S., Al Haddad, M., AlSeaidan, M., Al-Muhaini, A. Y., Al-Ghimlas, F., Al-Sabah, S. K.
10.1101/2020.05.21.20108639 — Posted: 2020-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).